NCT01375972View on ClinicalTrials.gov

Trial of S-1 Plus Cisplatin (SP) Versus Gemcitabine Plus Cisplatin (GP) in Advanced Biliary Tract Adenocarcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

July 31, 2011

Study Completion Date

August 31, 2011

Conditions
Metastatic Biliary Cancer
Interventions
DRUG

S-1 plus cisplatin

S-1 40 mg/m2 D1-D14 Cisplatin 60 mg/m2 D1 every 3 weeks

DRUG

Gemcitabine plus Cisplatin

Gemcitabine 1000 mg/m2 IV D1, D8 Cisplatin 60 mg/m2 IV D1 Every 3 weeks

Trial Locations (1)

138736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER